ClinConnect ClinConnect Logo
Search / Trial NCT06049433

Maternal Mental Health Access - MaMa

Launched by UNIVERSITY OF UTAH · Sep 20, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The MaMa trial is studying how to improve mental health support for women who are at risk for postpartum depression or perinatal depression, which can occur during pregnancy or after giving birth. The goal is to test a new way of providing mental health care remotely, using an on-demand program that can be accessed through a patient portal. Researchers want to understand how well this program works and how it can be effectively integrated into regular healthcare settings for women in different communities, including those in rural and urban areas, as well as Latino populations.

To participate in the trial, women must be at least 18 years old and either pregnant or within one year of giving birth. They should also be identified as at-risk for depression based on certain criteria, such as having a specific score on a depression screening tool or a history of depression or anxiety. Participants can expect to receive support for their mental health needs through online resources, and their experiences will help researchers refine future studies to better serve women in similar situations. This trial is currently recruiting participants, and those interested in joining should be aware of the eligibility criteria, including that they should not have severe mental health issues or substance use disorders.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 18+ years of age, who at the time of screening
  • Have a viable pregnancy or are postpartum (up to 1 year)
  • * Identified as at-risk for PD (any one of the following:
  • EPDS score equal to or greater than 9 or less than 21
  • History of depression/anxiety
  • 2 or more significant life events)
  • English- or Spanish-speaking
  • Currently attending a UHealth clinic or rural public health partner clinic.
  • Exclusion Criteria:
  • Have a substance use disorder
  • Current diagnosis of serious mental illness, such as psychosis, schizophrenia, bipolar disorder, severe depression (including EPDS \> 20)
  • Severe anxiety, suicidality, or currently taking any medications for a mental health condition.

About University Of Utah

The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.

Locations

Salt Lake City, Utah, United States

Patients applied

0 patients applied

Trial Officials

Gwen Latendresse

Principal Investigator

University of Utah

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported